Lycopene's primary mechanism is singlet oxygen quenching — it neutralizes one of the most reactive free radical species in biological systems. In the prostate, lycopene concentrates at 3-10x plasma levels (active uptake) where it: (1) inhibits IGF-1 signaling (growth factor implicated in prostate cancer progression); (2) activates phase II detoxification enzymes; (3) inhibits NF-κB inflammatory signaling; and (4) reduces androgen receptor signaling. For cardiovascular protection, it prevents LDL oxidation (the initiating step in atherosclerosis) and improves endothelial function.
No significant drug interactions have been identified in clinical literature. Lycopene is a naturally occurring carotenoid with no known pharmacological interactions. As a fat-soluble compound, malabsorption conditions or drugs that impair fat absorption (orlistat) may reduce lycopene uptake.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.